Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JCR Pharmaceuticals CoTSE:4552 +7.16%42 Days Inventory is 663.42 as of Mar. 2026, which is 29% above its 10-year median of 513.74. GuruFocus rates TSE:4552 with a GF Score™ of 42/100 and a GF Value™ of 円770.84 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, JCR Pharmaceuticals Co ranks worse than 98.05% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
JCR Pharmaceuticals Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.14.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JCR Pharmaceuticals Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.46.
JCR Pharmaceuticals Co (TSE:4552) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
JCR Pharmaceuticals Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JCR Pharmaceuticals Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
JCR Pharmaceuticals Co Days Inventory Related Terms
JCR Pharmaceuticals Co Days Inventory Historical Data
* Premium members only.
The historical data trend for JCR Pharmaceuticals Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4552 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JCR Pharmaceuticals Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where JCR Pharmaceuticals Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co (TSE:4552) has a Days Inventory of 663.42 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JCR Pharmaceuticals Co and its competitors. This is 29% above median its historical median of 513.74. Over the past decade, JCR Pharmaceuticals Co's Days Inventory has ranged from 415.12 to 844.66. According to the industry distribution chart, JCR Pharmaceuticals Co ranks #905 out of 923 companies in the Drug Manufacturers industry, placing it in the top 98%.
Is JCR Pharmaceuticals Co's Days Inventory too high?
JCR Pharmaceuticals Co's current Days Inventory of 663.42 is 29% above median its 10-year median of 513.74. Over the past 10 years, this metric has ranged from a low of 415.12 to a high of 844.66. The Drug Manufacturers industry median Days Inventory is 164.38. JCR Pharmaceuticals Co's value of 663.42 is 303.6% above this industry median. Based on the distribution chart, JCR Pharmaceuticals Co ranks #905 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, JCR Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, JCR Pharmaceuticals Co ranks #905 out of 923 companies for Days Inventory. This places JCR Pharmaceuticals Co in the lower half of its industry. The industry median Days Inventory is 164.38. JCR Pharmaceuticals Co's value of 663.42 is 303.6% above this benchmark. Historically, JCR Pharmaceuticals Co's own Days Inventory has ranged from 415.12 to 844.66 over the past decade. While the company's 10-year median is 513.74 vs. the industry median of 164.38, JCR Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JCR Pharmaceuticals Co's current Days Inventory of 663.42 is 303.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on JCR Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JCR Pharmaceuticals Co's current Days Inventory is 663.42, which is 29% above median its own 10-year median of 513.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (TSE:4552) is currently considered Possible Value Trap. The stock's GF Value™ is 円770.84, compared to a current price of 円524.00 — trading 32% below its estimated fair value. The current Days Inventory is 663.42, which is 29% above median its 10-year median of 513.74 and 303.6% above the Drug Manufacturers industry median of 164.38. JCR Pharmaceuticals Co's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For JCR Pharmaceuticals Co (TSE:4552), the current Days Inventory is 663.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JCR Pharmaceuticals Co (TSE:4552) Overvalued in 2026?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued.
The current stock price of 円524.00 is trading 32% below its estimated GF Value™ of 円770.84.
GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for TSE:4552:
Days Inventory: 663.42 (29% above median its 10-year median of 513.74)
GF Value™: 円770.84 vs. price of 円524.00 (32% below fair value)
Industry Position: 303.6% above the Drug Manufacturers median (#905 of 923)
No single metric tells the full story. See the TSE:4552 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
42GF Score
Get the complete analysis for TSE:4552
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4552 has been successfully added to your 
